Log in to save to my catalogue

Frontiers in the COVID-19 vaccines development

Frontiers in the COVID-19 vaccines development

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_285607a7b4f84d04a6b8d53dcafe1fea

Frontiers in the COVID-19 vaccines development

About this item

Full title

Frontiers in the COVID-19 vaccines development

Publisher

London: BioMed Central Ltd

Journal title

Experimental hematology & oncology, 2020-09, Vol.9 (1), p.1-24, Article 24

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Novel corona virus caused pneumonia first reported in December, 2019 in Wuhan, China was later named COVID-19. Due to its special pathogenicity, COVID-19 transmitted with high speed beyond borders and has significantly affected normal life. Currently, no specific drugs, treatment or vaccines are available. Vaccine development for COVID-19 is a high...

Alternative Titles

Full title

Frontiers in the COVID-19 vaccines development

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_285607a7b4f84d04a6b8d53dcafe1fea

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_285607a7b4f84d04a6b8d53dcafe1fea

Other Identifiers

ISSN

2162-3619

E-ISSN

2162-3619

DOI

10.1186/s40164-020-00180-4

How to access this item